Partial left ventriculectomy: overall and late results in 44 class IV patients with 4-year follow-up

F A Lucchese1, J D Frota Filho, C Blacher

  • 1São Francisco Hospital at Complexo Hospitalar da Santa Casa, Porto Alegre, RS, Brazil.

Insights

Partial left ventriculectomy (PLV) improved cardiac function in dilated cardiomyopathy patients but had high mortality. PLV may serve as a bridge to heart transplantation for select patients.

Area of Science:

  • Cardiovascular Surgery
  • Cardiology
  • Heart Failure Management

Background:

  • Dilated cardiomyopathy (DCM) presents significant challenges in heart failure management.
  • Partial left ventriculectomy (PLV) is a surgical option explored for advanced DCM.

Purpose of the Study:

  • To report long-term outcomes of partial left ventriculectomy (PLV) in patients with dilated cardiomyopathy.
  • To evaluate the impact of PLV on ventricular function, quality of life, and survival rates.

Main Methods:

  • A cohort of 44 patients with dilated cardiomyopathy underwent PLV over a 4-year period.
  • Comprehensive assessments included echocardiograms, cardiac catheterization, and maximal oxygen consumption (VO2) stress tests.

Main Results:

  • Survivors showed improved ejection fraction (22.1% to 30.9%), reduced LV end-diastolic diameter (79.4 mm to 61.9 mm), and enhanced VO2 (8.8 to 15.8 mL/kg/min).
  • Significant improvements were also noted in non-survivors prior to death.
  • Survival rates at 3, 6, 12, and 18 months were 56.8%, 47.7%, 38.4%, and 35.9%, respectively, stabilizing around 32.7% long-term.
  • Arrhythmias and heart failure were primary causes of mortality.

Conclusions:

  • While PLV improves ventricular function and quality of life for survivors, high mortality remains a significant concern.
  • PLV can be a viable option for patients awaiting heart transplantation, particularly those with high pulmonary vascular resistance (PVR) or when other options are unavailable.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...